An energetic tale of AMPK-independent effects of metformin

Metformin has become a mainstay in the modest therapeutic armamentarium for the treatment of the insulin resistance of type 2 diabetes mellitus. Although metformin functions primarily by reducing hepatic glucose output, the molecular mechanism mediating this effect had remained elusive until recentl...

Full description

Saved in:

Bibliographic Details
Published in:	The Journal of clinical investigation Vol. 120; no. 7; pp. 2267 - 2270
Main Authors:	Miller, Russell A., Birnbaum, Morris J.
Format:	Journal Article
Language:	English
Published:	United States American Society for Clinical Investigation 01.07.2010
Subjects:	AMP-Activated Protein Kinases Biomedical research Carbohydrate Metabolism Care and treatment Cyclic adenylic acid Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Gene expression Gene Expression - drug effects Genetic aspects Health aspects Hepatocytes - drug effects Hepatocytes - metabolism Humans Hypoglycemic Agents - metabolism Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Insulin Resistance Liver - drug effects Liver - metabolism Metformin Metformin - metabolism Metformin - pharmacology Metformin - therapeutic use Physiological aspects Protein kinases Protein Kinases - metabolism Protein Kinases - pharmacology Signal Transduction - drug effects Type 2 diabetes United States
ISSN:	0021-9738, 1558-8238, 1558-8238
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!